Activin and Inhibin

GLPG2938 is a potent and selective S1P2 antagonist. GLPG2938 can be used for the research of idiopathic pulmonary fibrosisIn VitroGLPG2938 (0.5~5 μM: HPF cells) significantly prevents the S1P-mediated contraction at all tested concentrations. MCE

GLPG2938 is a potent and selective S1P2 antagonist. GLPG2938 can be used for the research of idiopathic pulmonary fibrosisIn VitroGLPG2938 (0.5~5 μM: HPF cells) significantly prevents the S1P-mediated contraction at all tested concentrations. MCE

GLPG2938 is a potent and selective S1P2 antagonist. GLPG2938 can be used for the research of idiopathic pulmonary fibrosisIn VitroGLPG2938 (0.5~5 μM: HPF cells) significantly prevents the S1P-mediated contraction at all tested concentrations. MCE

GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor. GLS-1-IN-1 shows inhibitory effect against Hep G2, MCF 7, and MCF 10A cells.Appearance:SolidBiological Activity:GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor. GLS-1-IN-1 shows inhibitory effect against

GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor. GLS-1-IN-1 shows inhibitory effect against Hep G2, MCF 7, and MCF 10A cells.Appearance:SolidBiological Activity:GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor. GLS-1-IN-1 shows inhibitory effect against

Glucocorticoid receptor agonist is a Glucocorticoid receptor agonist that acts on Glucocorticoid receptor ( GR ), progesterone receptor ( PR ) and mineralocorticoid receptor ( MR ) with the IC 50 values of 2.1 , 1200 and 210 nM, respectively.

Glucocorticoid receptor agonist is a Glucocorticoid receptor agonist that acts on Glucocorticoid receptor ( GR ), progesterone receptor ( PR ) and mineralocorticoid receptor ( MR ) with the IC 50 values of 2.1 , 1200 and 210 nM, respectively.

Glucocorticoid receptor agonist is a Glucocorticoid receptor agonist that acts on Glucocorticoid receptor ( GR ), progesterone receptor ( PR ) and mineralocorticoid receptor ( MR ) with the IC 50 values of 2.1 , 1200 and 210 nM, respectively.

Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC 50 of 2.8 nM extracted from patent WO2017210471A1, compound 41In VitroGlucocorticoid receptor agonist immunoconjugates are useful for treating autoimmune

Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC 50 of 2.8 nM extracted from patent WO2017210471A1, compound 41In VitroGlucocorticoid receptor agonist immunoconjugates are useful for treating autoimmune

Glucocorticoid receptor agonist-2 (compound 21) is an glucocorticoid receptor agonist with an IC 50 value of 6.6 nM. Glucocorticoid receptor agonist-2 can be used to synthesize anti-inflammatory ADC molecules. Glucocorticoid receptor agonist-2 is an

Glucocorticoid receptor modulator 1 is a highly potent and orally active non-steroidal selective glucocorticoid receptor modulator with an IC 50 value of 9 nM and 130 nM for NF-κB and AP-1 , respectively. Glucocorticoid receptor modulator 1 can